Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics

Pharmacoepidemiologic andin vitroevaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins

(2014) H. Schelleman et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacotherapy of Type 2 Diabetes Mellitus: An Update on Drug–Drug Interactions

(2014) Muhammad Amin et al.   DRUG SAFETY

Propensity Score Methods for Confounding Control in Nonexperimental Research

(2013) M. Alan Brookhart et al.  

Association Between Hypoglycemia and Dementia in a Biracial Cohort of Older Adults With Diabetes Mellitus

(2013) Kristine Yaffe   JAMA Internal Medicine

Drug-induced hypoglycaemia in type 2 diabetes

(2012) Berit Inkster et al.   Expert Opinion On Drug Safety

Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study

(2012) Etienne Gayat et al.   PHARMACEUTICAL STATISTICS

Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples

(2011) Jeremy A. Rassen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

SLCO1B1 Polymorphism and Oral Antidiabetic Drugs

(2010) Annikka Kalliokoski et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Anti-Infectives and the Risk of Severe Hypoglycemia in Users of Glipizide or Glyburide

(2010) H Schelleman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Do Statins Beneficially or Adversely Affect Glucose Homeostasis?

(2010) Michael S. Kostapanos et al.   Current Vascular Pharmacology

Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide

(2009) Olga L. Zharikova et al.   BIOCHEMICAL PHARMACOLOGY

Antidiabetic Action of Bezafibrate in a Large Observational Database

(2009) J. H. Flory et al.   DIABETES CARE

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects

(2009) Bo Tan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: Diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study

(2008) Naoko Tajima et al.   ATHEROSCLEROSIS

Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits

(2008) Adit A Ginde et al.   BMC Endocrine Disorders